Please Wait
Applying Filters...
menu
    • menu
    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Resveratrol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 263Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jupiter Neurosciences Hosts Live Investor Webinar On January 6
    Jupiter Neurosciences Hosts Live Investor Webinar On January 6

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209823/0/en/Join-Jupiter-Neurosciences-Exclusive-Live-Investor-Webinar-and-Q-A-Session-on-January-6.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Jupiter Neurosciences Thrives in First Year as Public Firm
    Jupiter Neurosciences Thrives in First Year as Public Firm

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198812/0/en/Jupiter-Neurosciences-Marks-Transformational-First-Year-as-a-Public-Company-Entering-2026-with-Powerful-Clinical-and-Commercial-Momentum.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Jupiter Neurosciences Cleared By FDA For Phase 2A Trial
    Jupiter Neurosciences Cleared By FDA For Phase 2A Trial

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181489/0/en/Jupiter-Neurosciences-Receives-FDA-Clearance-of-IND-Application-to-Initiate-Phase-2a-Clinical-Trial-of-JOTROL-in-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Jupiter Neurosciences Complies with Nasdaq Minimum Bid Price Rule
    Jupiter Neurosciences Complies with Nasdaq Minimum Bid Price Rule

    10 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/10/3113671/0/en/Jupiter-Neurosciences-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html

    GLOBENEWSWIRE
    10 Jul 2025
    Share Share
    Stopping dementia at the nose with combination of rifampicin and resveratrol
    Stopping dementia at the nose with combination of rifampicin and resveratrol

    30 Dec 2021

    // SCIENCEDAILY

    https://www.sciencedaily.com/releases/2021/12/211229084259.htm

    SCIENCEDAILY
    30 Dec 2021
    Share Share
    Jupiter Orphan Therapeutics Announces U.S. Patent Its Resveratrol Formulation
    Jupiter Orphan Therapeutics Announces U.S. Patent Its Resveratrol Formulation

    01 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/jupiter-orphan-therapeutics-announces-us-patent-for-its-resveratrol-formulation-301143877.html

    PRNEWSWIRE
    01 Oct 2020
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.